Great West Life Assurance CO Vanda Pharmaceuticals Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $204,160 - $313,395	-47,701 Reduced 42.9%	63,502 $274,000
Q2 2023 Aug 10, 2023	BUY	$5.9 - $6.95 $20,697 - $24,380	3,508 Added 3.26%	111,203 $735,000
Q1 2023 May 12, 2023	SELL	$6.18 - $7.99 $5,419 - $7,007	-877 Reduced 0.81%	107,695 $731,000
Q4 2022 Feb 10, 2023	BUY	$6.87 - $10.96 $313,952 - $500,861	45,699 Added 72.68%	108,572 $804,000
Q3 2022 Nov 01, 2022	BUY	$9.44 - $11.76 $67,552 - $84,154	7,156 Added 12.84%	62,873 $621,000
Q2 2022 Aug 12, 2022	BUY	$9.31 - $11.84 $518,725 - $659,689	55,717 New	55,717 $608,000
Q2 2022 Aug 09, 2022	SELL	$9.31 - $11.84 $450,306 - $572,677	-48,368 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$15.69 - $21.14 $502 - $676	-32 Reduced 0.07%	48,368 $758,000
Q2 2021 Aug 11, 2021	BUY	$15.71 - $21.51 $32,786 - $44,891	2,087 Added 4.51%	48,400 $1.04 Million
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $107,816 - $162,929	-8,034 Reduced 14.78%	46,313 $695,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $53,813 - $76,065	-5,508 Reduced 9.2%	54,347 $714,000
Q3 2020 Nov 17, 2020	BUY	$9.32 - $12.02 $382,613 - $493,457	41,053 Added 218.34%	59,855 $578,000
Q3 2020 Nov 13, 2020	SELL	$9.32 - $12.02 $446,558 - $575,926	-47,914 Reduced 71.82%	18,802 $181,000
Q2 2020 Aug 17, 2020	SELL	$9.66 - $12.02 $30,409 - $37,838	-3,148 Reduced 4.51%	66,716 $764,000
Q1 2020 May 14, 2020	BUY	$7.5 - $16.8 $21,292 - $47,695	2,839 Added 4.24%	69,864 $721,000
Q4 2019 Feb 11, 2020	BUY	$12.38 - $17.47 $829,769 - $1.17 Million	67,025 New	67,025 $1.1 Million
Q3 2019 Oct 25, 2019	SELL	$12.27 - $15.79 $858,752 - $1.11 Million	-69,988 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$18.97 - $31.47 $1.21 Million - $2 Million	63,676 Added 1008.81%	69,988 $1.69 Million
Q2 2018 Aug 10, 2018	SELL	$13.95 - $19.15 $41,738 - $57,296	-2,992 Reduced 32.16%	6,312 $120,000
Q4 2017 Feb 09, 2018	BUY	$12.85 - $18.1 $84,861 - $119,532	6,604 Added 244.59%	9,304 $141,000
Q3 2017 Nov 09, 2017	BUY	$15.4 - $18.85 $41,580 - $50,895	2,700	2,700 $48,000

Others Institutions Holding VNDA

# of Institutions

157

Shares Held

44.9M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$35.9 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$17.7 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$16 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.4 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$9.97 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $249M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account